Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00511381 · ClinicalTrials.gov registry record
Genetic Testing in Detection of Late-Onset Hearing Loss
A clinical trial, sponsored by Pediatrix.
- Completed
- Registry status
- 3,681
- Enrollment target
NCT00511381 is a clinical trial that has completed, run by Pediatrix. The registered enrollment target is 3,681 participants.
The verdict
NCT00511381 has completed, sponsored by Pediatrix.
- COMPLETED
- Registry status
- 3,681 participants
- Enrollment target
Study Summary
Two major limitations of existing audiometric newborn hearing screening programs are their inability to detect forms of deafness that are not expressed at birth and the low compliance with obtaining recommended audiologic confirmation and/or follow-up. Molecular genetic tests on blood spots from all newborns will identify those at risk for the most frequent causes of late-onset hearing loss and to add these infants to the group who should receive continued audiologic monitoring.
Interventions
- GENETIC No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,681 participants |
| Start Date | 2007-10 |
| Est. Completion | 2011-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00511381
The ClinicalTrials.gov registry entry for NCT00511381 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 3,681 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pediatrix, which has 28 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT00511381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00511381 about?
NCT00511381 is a clinical study titled "Genetic Testing in Detection of Late-Onset Hearing Loss". Two major limitations of existing audiometric newborn hearing screening programs are their inability to detect forms of deafness that are not expressed at birth and the low compliance with obtaining recommended audiologic confirmation and/or follow-up. Molecular genetic tests on blood spots from all...
What is the current status of trial NCT00511381?
This trial is currently completed. The enrollment target is 3,681 participants. The study started on 2007-10. Estimated completion is 2011-09.
What interventions are being tested in trial NCT00511381?
The interventions under investigation include: No intervention (GENETIC).
Who is sponsoring clinical trial NCT00511381?
This trial is sponsored by Pediatrix, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.